BiotechTube
Vivacy

Vivacy

Paris, France· Est.
vivacy.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Laboratoires Vivacy is a privately-held, commercial-stage leader in the global aesthetic medicine market, with a core focus on hyaluronic acid-based dermal fillers. The company differentiates itself through patented technologies like its HA stabilization (IPN-Like) and innovative delivery systems (Bi-SOFT®, Bi-FLEX®), alongside a strong commitment to anti-counterfeiting via its MyVivacy RFID traceability app. With products sold in over 70 countries and a deep presence in professional medical congresses, Vivacy has established a strong international brand trusted by dermatologists, surgeons, and aesthetic doctors.

Aesthetic MedicineAnti-AgingWomen's Intimate Health

Technology Platform

Proprietary hyaluronic acid (HA) stabilization technology (IPN-Like cross-linking) combined with patented injection delivery systems (Bi-SOFT®, Bi-FLEX®) and a digital RFID-based product traceability platform (MyVivacy).

Opportunities

The global dermal filler market is experiencing robust growth driven by demand for non-surgical aesthetics.
Vivacy's expansion into over 70 countries and its early-mover advantage in the intimate aesthetics niche (Desirial®) provide significant avenues for growth.
Continued innovation in delivery systems (e.g., Bi-FLEX®) can drive practitioner preference and market share.

Risk Factors

The company faces intense competition from larger, well-funded global aesthetics corporations.
Its business is highly dependent on regulatory approvals and maintaining an impeccable safety profile.
As a provider of elective procedures, it is also exposed to macroeconomic downturns that can reduce discretionary consumer spending.

Competitive Landscape

Vivacy competes in the global hyaluronic acid dermal filler market against major players like AbbVie (Allergan), Galderma, and Merz Pharma, as well as other specialized European manufacturers. Its competitive strategy relies on differentiated IP (IPN-Like technology, patented syringes), a strong 'Made in France' brand for quality, and a deep focus on educating and building loyalty among aesthetic healthcare professionals.

More companies in Biologics / Biosimilars →More companies in France →